Clinical Features, Prognosis, and Long-Term Response to Ranibizumab of Macular CNVs in Pattern Dystrophies Spectrum: A Pilot Study.

J Ophthalmol · 2021 · PMC8068556 · PMID 33953968

Europe PMC DOI

hedged sentences

0.0060

closest p · 0.1× alpha

0.0800

boldest claim

The sentences

highly significantp = 0.006actually significant

A highly significant difference was found in the presence of HRF, more frequent in the PD group ( X 2 = 7.50; p = 0.006).

also in 132,142 other papers

an encouraging trendp = 0.08so close (0.05 < p ≤ 0.1)

The presence of HCD was detected in 3 cases, but it does not satisfy the significance criteria, despite an encouraging trend ( Z = −1.73; p = 0.08).

also in 355 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.